Cipla to acquire South Africa-based Actor Pharma
This is a strategic acquisition for Cipla South Africa to unlock future growth opportunities and leverage cost synergies in the South African market, the drug major said.
Source: moneycontrol.com
Stay updated with breaking news from Cipla Ltd Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This is a strategic acquisition for Cipla South Africa to unlock future growth opportunities and leverage cost synergies in the South African market, the drug major said.
Actor was founded in 2009 and has quickly grown to become the fifth largest privately owned OTC player in the South African market. Actor specialises in OTC and generic medicine, where they have established strong consumer brands and identified niche prescription markets in categories of women's health, nasal, cough and cold and baby and child.